The Medical Devices market are defined as the market for instruments, patient used devices, reagents or other products/equipment which are used for diagnosis or treatment of various ailments. The distinguishing factor from pharmaceutical products is that they achieve primary action without being metabolized or by a chemical action. Medical device industry comprises of In-vitro diagnostics, diagnostic imaging, drug delivery devices, and devices for medical therapeutics in orthopedics, cardiology, neurology ,and others. This industry, also referred to as the medtech industry, is experiencing dynamic changes. Trends in 3-D printing, miniaturization, wireless technologies, and updation and changes by healthcare regulatory authorities are leading medical device makers to create innovations that will improve the quality of care and reduce costs.
Another factor which is likely to provide flip to the industry is increasing healthcare expenditure in developing countries of Latin America and Asia. Furthermore, epidemiology and patient population related factors driving need for improved healthcare such as rapidly aging population, increasing urbanization, and associated emergence of lifestyle-related illnesses—such as lung cancer and heart disease—are driving patient demand for imaging equipment, orthopedic implants, and cardiovascular devices in particular.
The major players in the medical devices market are Johnson and Johnson (U.S.), Medtronic, Covidien, Stryker Corporation (U.S.), Baxter International, and Becton and Dickinson.
1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 Medical Devices by Submarkets
4.1 In Vitro Diagnostics
4.2 Diagnostic Imaging
4.3 Drug Delivery Devices
4.4 Orthopedics
4.5 Wound Management
4.6 Opthalmology devices
4.7 Dental Devices
4.8 Diabetic Care Devices
4.9 Nephrology/Urology Devices
4.10 Ear, Nose & Throat Devices
4.11 Neurology Devices
4.12 Cardiology Devices
4.13 General & Plastic Surgery
4.14 Endoscopy
4.15 Dermatology Devices
4.16 Respiratory & Anesthesia Devices
4.17 Radiotherapy Devices
4.18 Apheresis
4.19 Mobility Aid Devices
4.20 Feeding Device(Nutrition)
4.21 Medical Automation
4.22 Patient Monitoring
4.23 Medical Simulation
4.24 Point of Care Testing
4.25 Oral Care Devices
4.26 Diagnostics
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE | PUBLISHED | |
---|---|---|
Nerve Repair & Regeneration Market Nerve Repair and Regeneration market was pegged at $4680.82 million in 2013 and expected to be $8112.19 million by 2018, growing at a CAGR of 11.6%. The neuromodulation market is the largest segment of $4.5 billion of overall Nerve Repair and Regeneration Market. Nerve Repair and Regeneration market segment includes direct nerve repair, nerve grafting, and stem cell therapy, while the neuromodulation segment includes internal stimulation devices such as Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), and external stimulation devices such as Transcranial Magnetic Stimulation (TMS) and Transcutaneous Electrical Nerve Stimulation (TENS). The main companies operating in peripheral nerve repair segment include Integra LifeSciences Corporation (U.S.), Stryker Corporation (U.S.), AxoGen, Inc. (U.S.), and Polyganics (The Netherlands). The key players in the neuromodulation segment include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.). |
Upcoming | |
Global Neurostimulation/Neuromodulation Market Global Neurostimulation/Neuromodulation market is expected to reach from $4503.9 million in 2013 to $7810.4 million by 2018 at a CAGR of 11.6%. The Neuromodulation market is the largest segment 96% of Nerve Repair & regeneration market. The market divided by 2 segments such as Internal Neuromodulation and External Neuromodulation. The internal neuromodulation devices market includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES), and external neuromodulation devices such as transcranial magnetic stimulation (TMS) and transcutaneous electrical nerve stimulation (TENS). Major players in the market include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.). |
Upcoming | |
North American Nerve Repair & Regeneration Market The North American Nerve Repair and Regeneration market was pegged at $2841.03 million in 2013 and expected to be $4709.59 million by 2018, growing at a CAGR of 10.6%. Nerve Repair and Regeneration market segment includes direct nerve repair, nerve grafting, and stem cell therapy, while the neuromodulation segment includes internal stimulation devices such as Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), and external stimulation devices such as Transcranial Magnetic Stimulation (TMS) and Transcutaneous Electrical Nerve Stimulation (TENS). The main companies operating The North American Nerve Repair and Regeneration market segment include Integra LifeSciences Corporation (U.S.), Stryker Corporation (U.S.), AxoGen, Inc. (U.S.), and Polyganics (The Netherlands). The key players in the neuromodulation segment include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.). |
Apr 2015 | |
European Nerve Repair & Regeneration Market The nerve repair and regeneration market in Europe has displayed significant growth at a CAGR of 11.9%. Germany garnered the maximum market share and is expected to grow at a CAGR of 11.1%, followed by France and the U.K. |
Apr 2015 | |
Asian Nerve Repair & Regeneration Market The Asian Nerve Repair and Regeneration market was pegged at $4680.82 million in 2013 and expected to be $8112.19 million by 2018, growing at a CAGR of 11.6%. market segment includes direct nerve repair, nerve grafting, and stem cell therapy, while the neuromodulation segment includes internal stimulation devices such as Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES), and external stimulation devices such as Transcranial Magnetic Stimulation (TMS) and Transcutaneous Electrical Nerve Stimulation (TENS). The main companies operating in peripheral nerve repair segment include Integra LifeSciences Corporation (U.S.), Stryker Corporation (U.S.), AxoGen, Inc. (U.S.), and Polyganics (The Netherlands). The key players in the neuromodulation segment include Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corp. (U.S.), St. Jude Medical, Inc. (U.S.), Enteromedics, Inc. (U.S.), Dynatronics Corp. (U.S.), and Neuronetics (U.S.). |
Mar 2015 | |
Asian Internal Neurostimulation The Asian internal neurostimulation market was $271.80 million in 2013, and expected to reach $546.6 million by 2018 at a CAGR of 15.0%. Internal Neurostimulation market segmented by 5 modalities includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES). Major players dominating the Internal Neurostimulation market are Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical (U.S.), Johnson & Johnson and Greenbatch Inc,. |
Mar 2015 | |
Global Internal Neurostimulation Market The Internal Neurostimulation market was $3903.2 million in 2013 and expected to reach $6828.8 million by 2018 at a CAGR of 11.8%. The Internal Neuromodulation market is the largest segment 87% of Overall Neurostimulation/Neuromodulation market. Internal Neurostimulation market segmented by 5 modalities includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES). Major players dominating the Internal Neurostimulation market include Medtronic, Boston Scientific, St. Jude Medical, Cyberonics, Enteromedics, Neurotech, Cerebomed, Microtransponder and BioControl Medical. |
Apr 2015 | |
European Internal Neurostimulation The European internal neurostimulation market was $947.8 million in 2013, and is expected to reach $1715.8 million by 2018 at a CAGR of 13.0%. Internal Neurostimulation market segmented by 5 modalities includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES). Major players dominating the Internal Neurostimulation market are Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical (U.S), and Neuronetics, Inc (U.S.). Emerging players in this market include Biocontrol Medical, ANM Neuromodulation GmbH and Magstim Company Limited. |
Upcoming | |
North American Internal Neurostimulation The North American Internal Neurostimulation market was $2548.27 million in 2013 and expected to reach $4242.09 million by 2018 at a CAGR of 10.7%. Internal Neurostimulation market segmented by 5 modalities includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES). Major players dominating the Internal Neurostimulation market include Medtronic, Boston Scientific, St. Jude Medical, Cyberonics, Enteromedics, Neurotech, Cerebomed, Microtransponder and BioControl Medical. |
Upcoming | |
Dental Devices Dental Devices can be segmented by Geographies and Submarkets. Geographies of Dental Devices are North America, Europe, Asia and Rest of World. Submarkets of Dental Devices are Dental Implants, Dental Equipment, Dental Lasers, Dental Radiology Equipment, Dental... |
Upcoming | |
Dental Diagnostic & Surgical Equipments Global dental diagnostic & surgical equipments Market have gained much importancein the total dental devices market. Dental diagnostic & surgical equipments Market can be segmented by Geographies, Products, Endusers, Companies and MacroIndicators. Deep dive analysis of the top players of this market have been considered in this report. |
Upcoming | |
Dermatology Devices The global dermatology devices market is expected to grow at a CAGR of 10.4% from 2014 to 2019. The rising incidence of various skin disorders such as melanoma, psoriasis, vascular lesions, and acne have led to an increased demand for dermatological devices and various procedures and surgeries for the treatment of these skin ailments. |
Jul 2015 | |
Dental Lasers Market The dental lasers market is estimated to grow at a CAGR of 8.4% from 2014 to 2019. The market for dental lasers has seen periodic technological advances, which greatly drives the market growth. The laser systems which were previously bulky are now available in small and portable models; they are handy and convenient to use. A few are also available in a structure similar to that of a dental hand piece. The latest models of these devices make use of modern fiber-optic delivery systems. |
Apr 2016 | |
General & Plastic Surgery General & Plastic Surgery and its peer markets - Respiratory & Anesthesia Devices,Opthalmology devices,In Vitro Diagnostics,Point of Care Testing,Diabetic Care Devices,Medical Aesthetics,Apheresis,Nephrology/Urology Devices,Intrauterine Contraceptive Devices and 20... |
Upcoming | |
Radiation Ablators Radiation Ablators adds up considerable share to the total Ablation Devices market. Radiation Ablators can be segmented by Applications, Companies, MacroIndicators, Geographies and Products. Deep dive analysis of the key players of this domain, have been considered in this report. |
Upcoming | |
Global Brachytherapy Market The global brachytherapy market was valued at $450 Million in 2013.Peers of Brachytherapy are Stereotactic Radiosurgery & Stereotactic Radiotherapy and Image Guided Radiation Therapy (IGRT) comprising respectively of the Global Radiation Ablators market. The Market is segmented on basis of products, applications and technology. Deep dive analysis of the top players of this domain, have been considered in the report. |
Upcoming | |
Global CCD Imagers Market Global CCD Imagers market can be segmented according to the products, types, applications and end users. Deep dive analysis of the top players of this domain, have been considered in this report. |
Upcoming | |
Global Trauma Fixation Devices The global trauma fixation devices market is expected to register a CAGR of 6.7% between 2014 and 2019. The internal trauma fixation devices segment accounted for the largest share (87.7%) of the overall trauma fixation devices market in 2014. This segment is expected to grow at a CAGR of 6.9% for the forecast period from 2014 to 2019. The plates segment accounted for the largest share (36.1%) of the overall internal trauma fixation devices market in 2014. This segment is expected to grow at a CAGR of 7.1% during the forecast period from 2014 to 2019 |
May 2015 | |
Payment Link for Solta Medical - Global Medical Aesthetics Market Payment Link for Solta Medical - Global Medical Aesthetics Market |
Upcoming | |
Global Aesthetic Lasers and Energy Devices Global Aesthetic Lasers and Energy Devices market can be segmented on the basis of Companies, Geographies, Technologies, Products. Deep dive analysis of the top players of this domain, have been considered in this report. |
Upcoming |